Korean J Med.  1999 Jan;56(1):25-32.

Cardiovascular Regulation of GABAB Receptor in the Spinal Cord of the Rats

Affiliations
  • 1Department of Internal Medicine, college of medicine, Sung Kyun Kwan University Samsung Medical Center, Seoul, Korea.

Abstract


OBJECTIVES
The purpose of present study is to investigate the influence of a spinal gamma-aminobutyric acid B (GABAB) receptor on a central regulation of blood pressure(BP) and heart rate(HR), and to define its mechanism in the spinal cord.
METHODS
In urethane-anesthetized, d-tubocurarine- paralyzed and artificially ventilated male Sprague-Dawley rats, intrathecal administration of drugs were carried out using injecton cannula(33-gauge stainless steel) through the guide cannula(PE 10) which was inserted intrathecally at lower thoracic level through the puncture of a atlantooccipital membrane.
RESULTS
Intrathecal injection of an GABAB receptor agonist baclofen(30, 60, 100 nmol) decreased both blood pressure and heart rate dose-dependently. Pretreatment with 8-bromo-cAMP(50 nmol), a cAMP analog or glipizide(50 nmol), a ATP-sensitive K+ channel blocker attenuated the depressor and bradycardic effects of baclofen (100 nmol) but not with 8-bromo-cGMP(50 nmol) a cGMP analog.
CONCLUSIONS
The GABAB receptor in the spinal cord plays an inhibitory role in central cardiovascular regulation and that this depressor and bradycardic actions are mediated by the decrease of cAMP via the inhibition of adenylate cyclase and the opening of K+ channel.


MeSH Terms

Adenylyl Cyclases
Animals
Baclofen
Blood Pressure
gamma-Aminobutyric Acid
Heart
Heart Rate
Humans
Injections, Spinal
Male
Membranes
Punctures
Rats*
Rats, Sprague-Dawley
Spinal Cord*
Baclofen
gamma-Aminobutyric Acid
Full Text Links
  • KJM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr